Nittayasoot, N.; Suphanchaimat, R.; Thammawijaya, P.; Jiraphongsa, C.; Siraprapasiri, T.; Ploddi, K.; Pittayawonganon, C.; Mahasirimongkol, S.; Tharmaphornpilas, P.
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study. Vaccines 2022, 10, 2123.
https://doi.org/10.3390/vaccines10122123
AMA Style
Nittayasoot N, Suphanchaimat R, Thammawijaya P, Jiraphongsa C, Siraprapasiri T, Ploddi K, Pittayawonganon C, Mahasirimongkol S, Tharmaphornpilas P.
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study. Vaccines. 2022; 10(12):2123.
https://doi.org/10.3390/vaccines10122123
Chicago/Turabian Style
Nittayasoot, Natthaprang, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, and Piyanit Tharmaphornpilas.
2022. "Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study" Vaccines 10, no. 12: 2123.
https://doi.org/10.3390/vaccines10122123
APA Style
Nittayasoot, N., Suphanchaimat, R., Thammawijaya, P., Jiraphongsa, C., Siraprapasiri, T., Ploddi, K., Pittayawonganon, C., Mahasirimongkol, S., & Tharmaphornpilas, P.
(2022). Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study. Vaccines, 10(12), 2123.
https://doi.org/10.3390/vaccines10122123
